Literature DB >> 25468970

Constitutively active Notch4 receptor elicits brain arteriovenous malformations through enlargement of capillary-like vessels.

Patrick A Murphy1, Tyson N Kim1, Lawrence Huang1, Corinne M Nielsen1, Michael T Lawton2, Ralf H Adams3, Chris B Schaffer4, Rong A Wang5.   

Abstract

Arteriovenous (AV) malformation (AVM) is a devastating condition characterized by focal lesions of enlarged, tangled vessels that shunt blood from arteries directly to veins. AVMs can form anywhere in the body and can cause debilitating ischemia and life-threatening hemorrhagic stroke. The mechanisms that underlie AVM formation remain poorly understood. Here, we examined the cellular and hemodynamic changes at the earliest stages of brain AVM formation by time-lapse two-photon imaging through cranial windows of mice expressing constitutively active Notch4 (Notch4*). AVMs arose from enlargement of preexisting microvessels with capillary diameter and blood flow and no smooth muscle cell coverage. AV shunting began promptly after Notch4* expression in endothelial cells (ECs), accompanied by increased individual EC areas, rather than increased EC number or proliferation. Alterations in Notch signaling in ECs of all vessels, but not arteries alone, affected AVM formation, suggesting that Notch functions in the microvasculature and/or veins to induce AVM. Increased Notch signaling interfered with the normal biological control of hemodynamics, permitting a positive feedback loop of increasing blood flow and vessel diameter and driving focal AVM growth from AV connections with higher blood velocity at the expense of adjacent AV connections with lower velocity. Endothelial expression of constitutively active Notch1 also led to brain AVMs in mice. Our data shed light on cellular and hemodynamic mechanisms underlying AVM pathogenesis elicited by increased Notch signaling in the endothelium.

Entities:  

Keywords:  Notch; angiogenesis; hereditary hemorrhagic telangiectasia; stroke; vascular anomaly

Mesh:

Substances:

Year:  2014        PMID: 25468970      PMCID: PMC4273347          DOI: 10.1073/pnas.1415316111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Notch4 normalization reduces blood vessel size in arteriovenous malformations.

Authors:  Patrick A Murphy; Tyson N Kim; Gloria Lu; Andrew W Bollen; Chris B Schaffer; Rong A Wang
Journal:  Sci Transl Med       Date:  2012-01-18       Impact factor: 17.956

2.  Arteriovenous malformations in five dimensions.

Authors:  Jan Kitajewski
Journal:  Sci Transl Med       Date:  2012-01-18       Impact factor: 17.956

3.  Endothelial expression of constitutively active Notch4 elicits reversible arteriovenous malformations in adult mice.

Authors:  Timothy R Carlson; Yibing Yan; Xiaoqing Wu; Michael T Lam; Gale L Tang; Levi J Beverly; Louis M Messina; Anthony J Capobianco; Zena Werb; Rong Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-30       Impact factor: 11.205

4.  Molecular identification of venous progenitors in the dorsal aorta reveals an aortic origin for the cardinal vein in mammals.

Authors:  Henrik Lindskog; Yung Hae Kim; Eric B Jelin; Yupeng Kong; Salvador Guevara-Gallardo; Tyson N Kim; Rong A Wang
Journal:  Development       Date:  2014-03       Impact factor: 6.868

5.  Constitutively active endothelial Notch4 causes lung arteriovenous shunts in mice.

Authors:  Doug Miniati; Eric B Jelin; Jennifer Ng; Jianfeng Wu; Timothy R Carlson; Xiaoqing Wu; Mark R Looney; Rong A Wang
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-11-20       Impact factor: 5.464

Review 6.  Arteriovenous malformations and other vascular malformation syndromes.

Authors:  Kevin J Whitehead; Matthew C P Smith; Dean Y Li
Journal:  Cold Spring Harb Perspect Med       Date:  2013-02-01       Impact factor: 6.915

7.  Endothelial Notch signaling is upregulated in human brain arteriovenous malformations and a mouse model of the disease.

Authors:  Patrick A Murphy; Gloria Lu; Steven Shiah; Andrew W Bollen; Rong A Wang
Journal:  Lab Invest       Date:  2009-06-22       Impact factor: 5.662

8.  Restricted expression of mutant SOD1 in spinal motor neurons and interneurons induces motor neuron pathology.

Authors:  Lijun Wang; Kamal Sharma; Han-Xiang Deng; Teepu Siddique; Gabriella Grisotti; Erdong Liu; Raymond P Roos
Journal:  Neurobiol Dis       Date:  2007-10-23       Impact factor: 5.996

9.  Notch1 activation in mice causes arteriovenous malformations phenocopied by ephrinB2 and EphB4 mutants.

Authors:  Luke T Krebs; Christa Starling; Alexander V Chervonsky; Thomas Gridley
Journal:  Genesis       Date:  2010-03       Impact factor: 2.487

10.  Pathogenesis of arteriovenous malformations in the absence of endoglin.

Authors:  Marwa Mahmoud; Kathleen R Allinson; Zhenhua Zhai; Rachael Oakenfull; Pranita Ghandi; Ralf H Adams; Marcus Fruttiger; Helen M Arthur
Journal:  Circ Res       Date:  2010-03-11       Impact factor: 17.367

View more
  29 in total

Review 1.  Molecular, Cellular, and Genetic Determinants of Sporadic Brain Arteriovenous Malformations.

Authors:  Brian P Walcott; Ethan A Winkler; Guy A Rouleau; Michael T Lawton
Journal:  Neurosurgery       Date:  2016-08       Impact factor: 4.654

2.  Common and specific effects of TIE2 mutations causing venous malformations.

Authors:  Marjut Nätynki; Jaakko Kangas; Ilkka Miinalainen; Raija Sormunen; Riikka Pietilä; Julie Soblet; Laurence M Boon; Miikka Vikkula; Nisha Limaye; Lauri Eklund
Journal:  Hum Mol Genet       Date:  2015-08-28       Impact factor: 6.150

3.  Elevated endothelial Sox2 causes lumen disruption and cerebral arteriovenous malformations.

Authors:  Jiayi Yao; Xiuju Wu; Daoqin Zhang; Lumin Wang; Li Zhang; Eric X Reynolds; Carlos Hernandez; Kristina I Boström; Yucheng Yao
Journal:  J Clin Invest       Date:  2019-06-24       Impact factor: 14.808

Review 4.  Pathogenesis of non-hereditary brain arteriovenous malformation and therapeutic implications.

Authors:  Takahiro Ota; Masaki Komiyama
Journal:  Interv Neuroradiol       Date:  2020-02-05       Impact factor: 1.610

5.  Superficial middle cerebral vein connection to the cavernous sinus is not infrequent in brain arteriovenous malformations: an argument against their congenital origin?

Authors:  Eimad Shotar; Alexis Guédon; Nader Sourour; Federico Di Maria; Joseph Gabrieli; Aurélien Nouet; Jacques Chiras; Frédéric Clarençon
Journal:  Neuroradiology       Date:  2016-03-28       Impact factor: 2.804

Review 6.  Vascular Integrity in the Pathogenesis of Brain Arteriovenous Malformation.

Authors:  Rui Zhang; Wan Zhu; Hua Su
Journal:  Acta Neurochir Suppl       Date:  2016

7.  Reductions in brain pericytes are associated with arteriovenous malformation vascular instability.

Authors:  Ethan A Winkler; Harjus Birk; Jan-Karl Burkhardt; Xiaolin Chen; John K Yue; Diana Guo; W Caleb Rutledge; George F Lasker; Carlene Partow; Tarik Tihan; Edward F Chang; Hua Su; Helen Kim; Brian P Walcott; Michael T Lawton
Journal:  J Neurosurg       Date:  2018-12-01       Impact factor: 5.115

8.  Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain.

Authors:  Sergey I Nikolaev; Sandra Vetiska; Ximena Bonilla; Emilie Boudreau; Suvi Jauhiainen; Behnam Rezai Jahromi; Nadiya Khyzha; Peter V DiStefano; Santeri Suutarinen; Tim-Rasmus Kiehl; Vitor Mendes Pereira; Alexander M Herman; Timo Krings; Hugo Andrade-Barazarte; Takyee Tung; Taufik Valiante; Gelareh Zadeh; Mike Tymianski; Tuomas Rauramaa; Seppo Ylä-Herttuala; Joshua D Wythe; Stylianos E Antonarakis; Juhana Frösen; Jason E Fish; Ivan Radovanovic
Journal:  N Engl J Med       Date:  2018-01-03       Impact factor: 91.245

9.  Mouse Models of Cerebral Arteriovenous Malformation.

Authors:  Corinne M Nielsen; Lawrence Huang; Patrick A Murphy; Michael T Lawton; Rong A Wang
Journal:  Stroke       Date:  2015-09-08       Impact factor: 7.914

Review 10.  Role of Delta-Notch signaling in cerebral cavernous malformations.

Authors:  Souvik Kar; Arpita Baisantry; Arya Nabavi; Helmut Bertalanffy
Journal:  Neurosurg Rev       Date:  2016-01-16       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.